Measures how consequential and binary the catalyst is. Major regulatory decisions generally carry more shock than routine updates.
HOW THE MODEL WORKS
How The Observer turns regulatory events into a research-priority view.
The model is designed to help prioritize independent research. It scores relative issuer sensitivity using the event, the company’s exposure and company context; it does not predict regulatory approval, price direction, price magnitude or investment return.
CATALYST SENSITIVITY
Four model bands
Limited0–24
Lower modeled issuer sensitivity to this specific catalyst.
Moderate25–44
Moderate modeled sensitivity, with meaningful but non-dominant company exposure.
Strong45–74
High modeled sensitivity because the event may materially change expectations for an important program.
Major75–100
Very high modeled sensitivity, typically where event shock and company exposure are both substantial.
A card can span more than one band. For example, Strong → Major means the model’s lower and upper sensitivity estimates fall in different categories. The score is a research-prioritization indicator only and is not a forecast of price direction or magnitude.
WHAT DRIVES THE SCORE
Event + exposure + company context
Estimates how economically important the drug or program may be to the company. Greater concentration can increase the event's relative materiality to the issuer.
Adds relative scale context. A single catalyst can matter very differently to a small biotech than to a diversified large pharmaceutical company.
CONFIDENCE
How evidence quality is graded
Confidence describes how well the Catalyst Sensitivity score is supported by evidence. It is not the probability that a regulator will approve or reject a drug and is not a probability of any market outcome.
PrimarySource quality
Regulator pages and SEC filings are preferred, followed by company investor-relations and press-release pages. Secondary sources carry less influence.
SupportSupporting evidence
Broader supporting evidence can strengthen confidence in the research score.
RecentFreshness
More recent evidence generally provides stronger support than stale information.
CoverageData completeness
Confidence improves when the underlying company and asset data are more complete.
The Observer publishes the factors users need to interpret confidence, but its internal weighting, thresholds, normalization and matching logic are proprietary. Social-media posts are not treated as primary evidence. Unclear or weakly matched information can remain pending instead of being treated as confirmed.
INTERPRETATION
Materiality is not a trading forecast
A high Catalyst Sensitivity score means the model considers the issuer comparatively sensitive to that catalyst based on event shock, exposure and company context. It does not say whether a security should be bought or sold, whether the event will be positive or negative, or how a market price will move.
Scores are rules-based research indicators and can change as evidence, dates, company mappings or underlying asset information improve. Coverage cannot be guaranteed complete or instantaneous. Verify material information with the linked primary source and conduct your own research before making decisions.